3,630 Shares in CVS Health Co. (NYSE:CVS) Acquired by Marquette Asset Management LLC

Marquette Asset Management LLC bought a new stake in CVS Health Co. (NYSE:CVSFree Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 3,630 shares of the pharmacy operator’s stock, valued at approximately $228,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. First Financial Bankshares Inc acquired a new stake in CVS Health in the fourth quarter worth $1,117,000. Avidity Partners Management LP purchased a new stake in CVS Health in the fourth quarter worth $58,430,000. Continuum Advisory LLC boosted its holdings in CVS Health by 16.1% in the 4th quarter. Continuum Advisory LLC now owns 31,881 shares of the pharmacy operator’s stock worth $2,517,000 after buying an additional 4,422 shares during the period. Midland Wealth Advisors LLC bought a new position in shares of CVS Health in the fourth quarter worth $1,315,000. Finally, Comerica Bank grew its holdings in CVS Health by 0.8% during the 4th quarter. Comerica Bank now owns 420,164 shares of the pharmacy operator’s stock valued at $33,176,000 after buying an additional 3,305 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on CVS shares. Wells Fargo & Company raised their price objective on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research report on Monday, August 12th. Deutsche Bank Aktiengesellschaft cut their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $59.00 to $85.00 in a research report on Friday, October 4th. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. Finally, Evercore ISI upped their price target on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday. Ten equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $74.05.

Check Out Our Latest Report on CVS Health

CVS Health Stock Performance

Shares of CVS opened at $65.88 on Wednesday. The company has a market capitalization of $82.70 billion, a price-to-earnings ratio of 11.58, a price-to-earnings-growth ratio of 0.81 and a beta of 0.54. CVS Health Co. has a 52-week low of $52.77 and a 52-week high of $83.25. The stock has a 50 day moving average price of $58.67 and a 200 day moving average price of $61.25. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVSGet Free Report) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.10. The firm had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. CVS Health’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.21 earnings per share. Research analysts predict that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be issued a $0.665 dividend. The ex-dividend date is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.04%. CVS Health’s dividend payout ratio (DPR) is 46.75%.

CVS Health Company Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.